ESC 365 - Improved prognosis prediction of idiopathic pulmonary arterial hypertension using targeted plasma proteomics in disease management

ESC Professional Premium Access

Improved prognosis prediction of idiopathic pulmonary arterial hypertension using targeted plasma proteomics in disease management

Session: Molecular modifiers of pulmonary vascular disease

Topic: Pulmonary Hypertension

Speaker: Doctor Y. Yang (Beijing, CN)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Yicheng Yang

Beijing (China)

0 follower

7 more presentations in this session

CILP1 and NTproBNP in pulmonary hypertension and right ventricular pressure overload: a translational experimental study

Speaker: Doctor A. Garcia-Alvarez (Barcelona, ES)

Recruitment of CCR5-positive T cells in pulmonary vascular lesions in idiopathic- and connective tissue disease associated- pulmonary arterial hypertension

Speaker: Doctor K. Ohta-Ogo (Suita, JP)

Comprehensive bioinformatic analysis identified m6A methylation as an important regulator in mediating immune response during idiopathic pulmonary arterial hypertension

Speaker: Doctor N. Liu (Changsha, CN)

Ambrisentan reverses the prosenescent and anti-autophagic effect of high glucose on human pulmonary artery endothelial cells exposed to hypoxia

Speaker: Doctor F. Biondi (IT)

PEDF upregulated in Ngfr-positive cells suppresses proliferation of pulmonary artery smooth muscle cells

Speaker: Doctor C. Goten (Kanazawa, JP)

Access the full session

Molecular modifiers of pulmonary vascular disease

Speakers: Doctor Y. Yang, Doctor A. Garcia-Alvarez, Doctor K. Ohta-Ogo, Doctor N. Liu, Doctor F. Biondi...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources